earnings
EV
NYSE · EVMN
Evommune, Inc.
Healthcare · Biotechnology
$9.99
Down-$0.44 (-4.22%)
Updated Sep 16, 2026, 3:02 AM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 261.72M
- P/E ratio
- -21.13
- Dividend yield
- 0.00%
- 52-week range
- $10.30 – $29.07
- Volume
- 520K
- Avg. volume
- 205.5K
Price performance
EVMN price history
1M range · 20 trading sessions · Daily adjusted prices
EVMN closed at $9.99 after 20 trading sessions, down 29.75% for the selected period.
- Last close
- $9.99
- Period change
- -29.75%
- Period low
- $9.99
- Period high
- $15.01
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $10.43 | $10.43 | $9.80 | $9.99 | 520K |
| Sep 14, 2026 | $10.49 | $10.6259 | $10.31 | $10.43 | 350.2K |
| Sep 11, 2026 | $10.66 | $10.82 | $10.50 | $10.54 | 388.92K |
| Sep 10, 2026 | $10.50 | $11.03 | $10.31 | $10.56 | 692.62K |
| Sep 9, 2026 | $11.90 | $12.10 | $10.3001 | $10.84 | 3.99M |
| Sep 8, 2026 | $12.11 | $13.35 | $12.01 | $13.08 | 1.24M |
| Sep 4, 2026 | $11.87 | $12.455 | $11.87 | $12.27 | 249.09K |
| Sep 3, 2026 | $12.70 | $12.70 | $11.70 | $12.00 | 594.24K |
| Sep 2, 2026 | $12.50 | $12.80 | $12.33 | $12.48 | 370.58K |
| Sep 1, 2026 | $12.50 | $12.735 | $12.42 | $12.48 | 278.49K |
| Aug 31, 2026 | $13.08 | $13.13 | $12.61 | $12.66 | 571.96K |
| Aug 28, 2026 | $13.48 | $13.65 | $12.97 | $13.23 | 350.57K |
| Aug 27, 2026 | $14.13 | $14.175 | $13.41 | $13.48 | 252.5K |
| Aug 26, 2026 | $14.17 | $14.28 | $13.59 | $14.11 | 343.01K |
| Aug 25, 2026 | $13.79 | $14.4418 | $13.60 | $13.79 | 340.39K |
| Aug 24, 2026 | $13.91 | $13.91 | $13.03 | $13.67 | 228.58K |
| Aug 21, 2026 | $13.74 | $14.25 | $13.70 | $14.02 | 326.55K |
| Aug 20, 2026 | $14.76 | $14.76 | $13.20 | $13.57 | 764.81K |
| Aug 19, 2026 | $14.57 | $15.06 | $14.475 | $15.01 | 293.2K |
| Aug 18, 2026 | $14.09 | $14.53 | $14.07 | $14.22 | 322.43K |
Latest EVMN news
The latest Smart Investors Daily articles mentioning EVMN.
Stock researchResearch & News · Competitors
Loading stock research…

